Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

BARD1 LIFE SCIENCES LIMITED

Date of this announcement

Monday November 22, 2021

The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

BD1AE

OPTION EXPIRING VARIOUS DATES EX

50,000

19/11/2021

VARIOUS PRICES

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

BARD1 LIFE SCIENCES LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

58009070384

1.3

ASX issuer code

BD1

  1. The announcement is New announcement
  2. Date of this announcement

22/11/2021

Notification of Issue, Conversion or Payment up of Unquoted

2 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX

For personal use only

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

has an existing ASX security code ("existing class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to ASX in an Appendix 3B

only

ASX +security code and description

BD1AE : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Date the +securities the subject of this notification were issued

19/11/2021

use

Will these +securities rank equally in all respects from their issue date with the existing issued

+securities in that class

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

No

personalFor

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme

or a summary of the terms

https://wcsecure.weblink.com.au/pdf/BD1/02158299.pdf

Any other information the entity wishes to provide about the +securities the subject of this notification

I ue details

Number of +securities 50,000

Notification of Issue, Conversion or Payment up of Unquoted

4 / 6

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 4 - +Securities on issue

For personal use only

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

Total number of

ASX +security code and description

+securities on issue

BD1 : ORDINARY FULLY PAID

91,934,920

BD1O : OPTION EXPIRING 24-AUG-2023

5,909,965

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

Total number of

ASX +security code and description

+securities on issue

BD1AE : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

1,345,790

BD1AF : OPTION EXPIRING 20-NOV-2023 EX $1.86

166,667

Notification of Issue, Conversion or Payment up of Unquoted

5 / 6

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

BARD1 Life Sciences Ltd. published this content on 22 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 November 2021 04:23:00 UTC.